Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Tvardi Therapeutics (TVRD) Leases (2019 - 2025)

Tvardi Therapeutics' Leases history spans 7 years, with the latest figure at $144000.0 for Q4 2025.

  • On a quarterly basis, Leases fell 33.33% to $144000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $144000.0, a 33.33% decrease, with the full-year FY2025 number at $144000.0, down 33.33% from a year prior.
  • Leases hit $144000.0 in Q4 2025 for Tvardi Therapeutics, down from $163000.0 in the prior quarter.
  • Over the last five years, Leases for TVRD hit a ceiling of $7.1 million in Q3 2023 and a floor of $144000.0 in Q4 2025.
  • Historically, Leases has averaged $2.5 million across 5 years, with a median of $2.5 million in 2022.
  • The widest YoY moves for Leases: up 360.35% in 2024, down 95.56% in 2024.
  • Tracing TVRD's Leases over 5 years: stood at $3.0 million in 2021, then plummeted by 47.83% to $1.6 million in 2022, then soared by 213.6% to $4.9 million in 2023, then plummeted by 95.56% to $216000.0 in 2024, then tumbled by 33.33% to $144000.0 in 2025.
  • Business Quant data shows Leases for TVRD at $144000.0 in Q4 2025, $163000.0 in Q3 2025, and $181000.0 in Q2 2025.